BostonGene
In Brief This Week:, Hologic, Revvity, Pillar Biosciences, Mainz Biomed, More
News items for the week of Oct. 21, 2024.
BostonGene, Sylvester Comprehensive Cancer Center Partner on Hematologic Cancer Molecular Subtyping
Researchers will compare traditional tumor profiling methods such as FISH and cytogenetics to BostonGene's AI-powered molecular and immune profiling platform.
BostonGene, Exigent Research Ink Trial Agreement for Study of Comprehensive Cancer Sequencing
Using patient tumor samples from participating Exigent sites, BostonGene aims to validate its exome and RNA sequencing assay in a real-world setting.
BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy
Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.
BostonGene Partners with NEC to Offer Tumor Portrait Tests Internationally
NEC, an investor in BostonGene, will initially help provide Tumor Portrait to hospitals in Japan using its healthcare and life science network.